CD Skripsi
Perbandingan Kadar Hba1c Penyintas Dan Bukan Penyintas Pasien Covid-19 Komorbid Diabetes Melitus Di Rsud Arifin Achmad Provinsi Riau
ABSTRACT
COMPARISON OF HBA1C LEVELS IN SURVIVED AND NON-SURVIVED PATIENTS WITH COVID-19 COMBORBID DIABETES MELLITUS AT THE ARIFIN ACHMAD REGIONAL HOSPITAL OF RIAU PROVINCE
By
Annisa Viani Khalda
Coronavirus Disease-2019, or COVID-19, was caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which was contagious and attacked the body through Angiotensin Converting Enzyme-2 (ACE-2) receptors. The progress of COVID-19 was influenced by various comorbid diseases, one of which was Diabetes Mellitus. Diabetes Mellitus (DM) was the second most common comorbid disease after hypertension in COVID-19 patients. The risk of complications of DM could be controlled and reduced by controlling blood sugar levels. The HbA1c parameter was described as the golden standard for evaluating the average value of blood glucose levels over the last three months. This study compared the HbA1c levels of survivors and non-survivors of COVID-19 patients with comorbid DM at Arifin Achmad Hospital, Riau Province. The design of this study was an analytical study (cross-sectional) using the total sampling method for the period March 2020-March 2021 with a total sample of 44 people. The results of this study indicated that the characteristics of majority of respondents were male, which were 24 people (54.5%), and the largest age group was the range of 18-59 years, which were 26 people (59.1%). The average HbA1c value for survivors was (9.409% ± 2.3129) and the average for non-survivors was (9.290% ± 3.0172). Based on statistical tests, there was no significant difference in the HbA1c levels of survivors and non-survivors of COVID-19 with comorbid DM (p>0.05).
Keywords: HbA1c, survivors, non-survivors, COVID-19, DM
Tidak tersedia versi lain